This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. The latest issue of the Medical Devices TOE profiles innovations across the innovation ecosystem and the breadth of the medical devices industry. These include innovations from university research labs, start-up companies, corporations and findings from clinical trials. The innovations come from diverse fields such as super-capacitors for implantab...

    $950.00
  2. Cancer immunotherapy and cancer profiling are key areas of growth across the healthcare community. These vital areas will define the future of how cancer is screened, diagnosed, managed, and monitored. With technology areas such as exosome technology being implemented in profiling tumors, a paradigm shift can be brought about in how cancer is detec...

    $250.00
  3. Personalized medicine has brought forth a new avenue for innovation. Currently, genomics is being accelerated into extensive use across drug development and drug discovery. The capability of genomics has brought about the resurgence of biomarkers that could effective patient stratification, ensuring the right drugs are developed to treat a specific...

    $950.00
  4. This edition of the Future Tech TOE primarily encompasses comprehensive analyses of key emerging therapies across multiple sclerosis (MS). The service also includes treatment overviews, clinical pipeline analysis, IP and funding analysis, and emerging innovations across MS therapies. Furthermore, the research features the impact of key technology...

    $750.00
  5. Innovations across health and wellness are improving the quality of diagnosis and prevention. Currently, preventative solutions are gaining a wider acceptance, while solutions like probiotics that supplement the nutrition needs of an individual are important for ensuring a healthy population. However, the current state of diagnosis needs to ensure ...

    $250.00
  6. This Genetic Technology TOE depicts recent diagnostic and therapeutic advances across the global healthcare industry. Clinical trial scenario for monoclonal antibody therapies for migraine are also depicted. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunitie...

    $250.00
  7. 28 Apr 2017  |  Global

    Innovations in Biomedical Imaging

    The latest issue of Medical and Diagnostic Imaging TOE profiles innovations in biomedical imaging. Some of the profiles covered include magnetic resonance imaging (MRI) for targeted drug delivery, computerized blood flow simulation with MRI scans, next-generation contrast agents, upper extremity MRI modality, tablet-controlled computed tomography s...

    $950.00
  8. This Genetic Technology TOE depicts trends across the skin testing sector. Technology profiles for skin mimicking, tissue models, in vitro testing and tissue engineering approaches are presented. Clinical trials scenario for skin irritation testing is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engi...

    $250.00
  9. The latest issue of the Medical Devices TOE profiles eight innovations spanning the breadth of the MedTech space. These include synthetic surgical adhesives and sealants, non-invasive biomarker analysis for early cancer detection, borate-based bioactive wound dressing, a nanoscale glass for lab-on-a-chip devices, and a wrist worn wearable and healt...

    $950.00
  10. 21 Apr 2017  |  Global

    Advances in Liquid Biopsy Platforms

    This Genetic Technology TOE depicts trends across liquid biopsy platforms. The advent of novel antibody-based and targeted small molecule therapies have greatly improved the management of cancer disease. However, there is a growing need for robust monitoring platforms for enhanced assessment of diseases progression and treatment monitoring in cance...

    $250.00